Precision Insights

Our mission is to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine and life science industry.

Contact US

Precision Insights

Our mission is to provide market intelligence and strategic vision to drive disruption and innovation in precision medicine.

Contact US
Latest Insights
Pharma & Biotech
Explainable, Unbiased AI and Computational Systems Pathology: Q&A with Dusty Majumdar and Chakra Chennubhotla of SpIntellx
DeciBio interviews Dusty Majumdar and Chakra Chennubhotla, CEO and CTO at SpIntellx.
September 22, 2022
Pharma & Biotech
Explainable, Unbiased AI and Computational Systems Pathology: Q&A with Dusty Majumdar and Chakra Chennubhotla of SpIntellx
DeciBio interviews Dusty Majumdar and Chakra Chennubhotla, CEO and CTO at SpIntellx.
September 22, 2022
Clinical Diagnostics
Digital Pathology for Biomarker Development: Decibio’s Q&A with Chan-Young Ock of Lunit
Decibio interviews Dr. Chan-Young Ock of recently IPO’d digital pathology firm, Lunit.
September 12, 2022
Clinical Diagnostics
Digital Pathology for Biomarker Development: Decibio’s Q&A with Chan-Young Ock of Lunit
Decibio interviews Dr. Chan-Young Ock of recently IPO’d digital pathology firm, Lunit.
September 12, 2022
Clinical Diagnostics
Oncologist Perspectives on the Most Exciting Advancements in Precision Medicine
DeciBio conducted a pulse survey with 8 U.S. oncologists to ascertain what precision oncology advancements excite them the most.
September 15, 2022
Clinical Diagnostics
Oncologist Perspectives on the Most Exciting Advancements in Precision Medicine
DeciBio conducted a pulse survey with 8 U.S. oncologists to ascertain what precision oncology advancements excite them the most.
September 15, 2022
Pharma & Biotech
Mark a Course for the Future – Biomarkers in Cancer Immunotherapy
Here we explore how biomarkers are driving the immuno-oncology landscape. We dive into cutting-edge biomarker research and the challenges facing the field.
September 15, 2022
Pharma & Biotech
Mark a Course for the Future – Biomarkers in Cancer Immunotherapy
Here we explore how biomarkers are driving the immuno-oncology landscape. We dive into cutting-edge biomarker research and the challenges facing the field.
September 15, 2022
View All Insights
Our Work

We work with leading diagnostic, research tools, pharmaceutical, biotech, and health technology companies to tackle challenging strategic questions.

Research Tools
Clinical Diagnostics
Pharma & Biotech
Financial Services

Strategy Consulting

We are experts at conducting strategic overhauls, new product expansions, and commercial due diligence.

Learn More about Us

Data & Platforms

Our team provides bottom-up data products and SaaS platforms, to facilitate decision-making.

VIew all Data & platforms
Client Results

Our Impact

We answer complex market questions regarding innovative technological applications.

See ALL Client Results
Pharma & Biotech
Biopharma Genomic Testing Market Research
A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy
Clinical Diagnostics
Minimal Residual Disease (MRD) Application Prioritization and Evidence Generation Strategy
A leader in ctDNA testing was interested in investigating the opportunity for their assay to support treatment decision-making in 2 tumor types of interest (including 6 cancer subtypes)
Application Identification
Go-to-Market Strategy
Research Tools
Methylation Analysis Opportunity Identification for Ultra-Sensitive Detection Platform
A leader in research tools and clinical diagnostic development asked us to evaluate the opportunity for an ultrasensitive detection platform in methylation analysis
Application Identification
Target Identification
Pharma & Biotech
Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment
A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.
Voice-Of-Customer Research
Pricing Strategy
Careers

Become a DeciBion

Our team is multi-faceted but united by the "decibionic" energy that drives us to transform the precision medicine field.

Start Here

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Customer love

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc dignissim, mi et varius malesuada Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Precision Medicine. Precision Insights.
© DeciBio 2022. All rights reserved.
Privacy | Terms & Conditions